ASX exchange. Sector: Healthcare. Industry: Drug Manufacturers—Specialty & Generic. Location Australia, Laverton North.

Probiotec Limited [PBP.AXAustralia

2.21USD0.01 (+0.45%)

• At close Fri Oct 07 2022

118,083,984 USD
MARKET CAP
42.593
PE
0.496
BETA (5y)
0.054
EPS

profit

351%

for 5 years

profit

47%

for 3 years

profit

8%

for 2 years

profit

2%

for 1 year

profit

1%

for this year

About Probiotec Limited

Probiotec Limited engages in the development, manufacture, packing, and sale of pharmaceuticals, consumer health, and fast moving consumer products in Australia and internationally. The company provides contract manufacturing services for solid dose tablets, capsules, and caplets; tablets coating; blister packing; liquids, creams, gels, ointments, and suspensions; powders and powder blending; and sprays, as well as manufactures and packages finished doses. It also offers analytical and stability testing services; new product formulation and production trials, and ongoing research and development services; and packaging options for human and animal nutrition products, as well as manufactures and exports a range of nutraceuticals and functional ingredient raw materials. In addition, the company provides packing services pharmaceutical, consumer, healthcare, cosmetics, and food and beverage companies. Probiotec Limited was incorporated in 1996 and is headquartered in Laverton North, Australia.

Innovation. Experience. Quality. The Probiotec Group are leaders in the contract manufacturing and packing space, providing an extremely wide range of services across a portfolio that covers almost every consumer packaged good format. Talk to us about your manufacturing, primary or secondary packing work. OUR BUSINESSES

Probiotec Limited
https://www.probiotec.com.au
© 2022 avazzy.com. All rights reserved
Make with 🤎 and ☕ for you!

Investing involves risk, including possible loss of principal.

The strategies discussed are strictly for illustrative and educational purposes and are not a recommendation, offer or solicitation to buy or sell any securities or to adopt any investment strategy. There is no guarantee that any strategies discussed will be effective.

International investing involves risks, including risks related to foreign currency, limited liquidity, less government regulation and the possibility of substantial volatility due to adverse political, economic or other developments. These risks often are heightened for investments in emerging/ developing markets or in concentrations of single countries.